Skip to content
The Nexus
DossierENTITY

Most-Favored-Nation clause

Coverage of Most-Favored-Nation clause in the Nexus archive.

Earliest in view: Jul 22 · 14:52 UTCMost recent: Jul 22 · 14:52 UTC
Co-mentioned in this coverage
European Commissionorganization1Donald Trumpperson1Turnberry trade agreementtopic1Medicines for Europeorganization1Sandozorganization1
Recent coverage
  • BUSINESSJul 22 · 14:52 UTCPOLITICO EUROPE
    EU sieht sich von Trumps neuen Generika-Zöllen nicht betroffen

    The European Commission states that EU generic drugs are likely excluded from Trump's proposed 100% tariffs due to the 2025 Turnberry trade agreement, which mandates a 0% duty via the Most-Favored-Nation (MFN) clause. Trump's plan to impose tariffs on generics from 2028 aims to revive U.S. pharmaceutical production, but EU officials emphasize the agreement protects EU exports. The EU warns of potential retaliatory measures if the U.S. violates the accord.

Most-Favored-Nation clause · Dossier · The Nexus